Pilot Trial of Selecting Molecularly-Guided Therapy for Patients with non-V600 BRAF Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team

Por LoRusso, Patricia M., Boerner, Scott A., Pilat, Mary Jo, Forman, Karen M., Zuccaro, Clarice Y., Kiefer, Jeffrey A., Liang, Winnie S., Hunsberger, Sally, Redman, Bruce G., Markovic, Svetomir N., Sekulic, Aleksandar, Bryce, Alan H., Joseph, Richard W., Cowey, C. Lance, Fecher, Leslie Anne, Sosman, Jeffrey Alan, Chapman, Paul B., Schwartz, Gary K., Craig, David W., Carpten, John D., Trent, Jeffrey M.
Publicado no Mol Cancer Ther (2015)